Internal Medicine, Hematology & Oncology · Knoxville, TN
NPI
1144332495
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1415 Old Weisgarber Rd Ste 200
Knoxville, TN, 37909
Phone (865) 934-5800
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.0M
206,207 services
Medicare patients, 2024
618
Average age 74
Drug cost, 2024
$4.4M
2,000 prescriptions
Company payments, 2025
$3,154
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sudarshan R Doddabele was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 35,700 times for 24 patients. In total Sudarshan R Doddabele billed 206,207 services in 149 codes, and Medicare paid $3.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 35,700 | 24 | $0.26 | $9,432 |
| J0185 Injection, aprepitant, 1 mg | Office | 9,360 | 15 | $1.35 | $13K |
| J0897 Injection, denosumab, 1 mg | Office | 7,800 | 46 | $20.38 | $159K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,700 | 24 | $16.12 | $44K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,416 | 46 | $0.09 | $217 |
| 85025 Blood Count | Office | 1,921 | 468 | $7.58 | $15K |
| 36415 Venipuncture Blood Collection | Office | 1,764 | 466 | $8.60 | $15K |
| 80053 Clinical Chemistry | Office | 1,657 | 462 | $10.32 | $17K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,256 | 23 | $0.07 | $91.3 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 951 | 21 | $0.74 | $699 |
| 99214 Office E&M - Established | Office | 862 | 393 | $87.50 | $75K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 775 | 19 | $0.23 | $181 |
| 82728 Clinical Chemistry | Office | 622 | 262 | $13.27 | $8,256 |
| 83540 Clinical Chemistry | Office | 581 | 243 | $6.29 | $3,654 |
| 83550 Clinical Chemistry | Office | 578 | 242 | $8.51 | $4,919 |
By year: 2022 $2.2M for 183,001 services; 2023 $2.5M for 170,161 services; 2024 $3.0M for 206,207 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,921 | 468 | $7.58 | $15K |
| 36415 Venipuncture Blood Collection | 1,764 | 466 | $8.60 | $15K |
| 80053 Clinical Chemistry | 1,657 | 462 | $10.32 | $17K |
| 82728 Clinical Chemistry | 622 | 262 | $13.27 | $8,256 |
| 83540 Clinical Chemistry | 581 | 243 | $6.29 | $3,654 |
| 83550 Clinical Chemistry | 578 | 242 | $8.51 | $4,919 |
| 82784 Immunoassay | 409 | 83 | $9.10 | $3,722 |
| 82607 Clinical Chemistry | 358 | 243 | $14.76 | $5,282 |
| 83615 Clinical Chemistry | 317 | 218 | $5.90 | $1,871 |
| 83521 Immunoassay | 236 | 70 | $16.93 | $3,994 |
Medicare prescription drug claims, 2024
In 2024, the drug Sudarshan R Doddabele prescribed most often to Medicare patients was Ondansetron Hcl, with 114 prescriptions and refills. In total Sudarshan R Doddabele wrote 2,000 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 114 | 114 | 74 | $610 |
| Acyclovir Generic | 94 | 124 | 39 | $974 |
| Eliquis Apixaban | 86 | 93 | 31 | $53K |
| Prochlorperazine Maleate Generic | 86 | 86 | 56 | $635 |
| Potassium Chloride Generic | 77 | 87 | 41 | $515 |
| Oxycodone Hcl Generic | 71 | 71 | 38 | $1,138 |
| Prednisone Generic | 57 | 59 | 39 | $226 |
| Dexamethasone Generic | 55 | 61 | 40 | $605 |
| Letrozole Generic | 55 | 123 | 21 | $614 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 54 | 57 | 21 | $156 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 53 | 53 | 30 | $1,040 |
| Anastrozole Generic | 51 | 125 | 23 | $641 |
| Allopurinol Generic | 47 | 63 | 22 | $256 |
| Hydroxyurea Generic | 44 | 53 | 11 | $625 |
| Mirtazapine Generic | 44 | 51 | 23 | $997 |
Brand drugs: - claims; generic drugs: 1,592 claims; opioid claims: 171.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sudarshan R Doddabele $3,154 ($3,154 in general payments such as food, travel and fees) from 46 companies. The largest payer was Daiichi Sankyo Inc. with $246.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 10 | $246 |
| E.R. Squibb & Sons, L.L.C. BMY | 19 | $243 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $204 |
| Gilead Sciences, Inc. GILD | 10 | $183 |
| Incyte Corporation INCY | 8 | $170 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $161 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $132 |
| Lilly USA, LLC LLY | 6 | $106 |
| EMD Serono, Inc. MRK.DE | 5 | $96.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.